数字农科院2.0

A neutralizing nanobody-based liquid-phase blocking ELISA to assess the protective potency of Senecavirus A vaccine

文献类型： 外文期刊

作者： Mu, Suyu;Pan, Songjia;Dong, Hu;Wu, Jinen;Zhang, Yun;Yin, Shuanghui;Wang, Jianing;Wei, Tian;Wen, Xiaobo;Guo, Huichen;Sun, Shiqi

作者机构：

关键词： Senecavirus A;Single-domain antibody;Neutralizing antibody;Liquid-phase blocking enzyme-linked immunosorbent assay;Senecavirus A challenge test

期刊名称： APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

ISSN： 0175-7598

年卷期： 2025 年 109 卷 1 期

页码：

收录情况： SCIE（2025版） ; ; EI（2025版）

摘要： Senecavirus A (SVA) causes swine blister diseases in the crown of hooves, abortion syndrome, and increased mortality rates in piglets. Vaccination is the best defense against SVA infection. However, evaluations of the efficacy of SVA vaccines currently rely on challenging pigs with SVA, which is time-consuming, labor-intensive, and inconsistent with animal welfare mandates. To establish a replacement for the virus neutralization test (VNT) and SVA challenge tests, we developed a liquid-phase blocking enzyme-linked immunosorbent assay (nbLPB-ELISA) based on V1-VHH as the coating antibody (Ab) and biotinylated V1-VHH as the detection Ab. Under optimized conditions, the VNT and nbLPB-ELISA results were strongly correlated (Pearson R-2 = 0.84; p < 0.00001). Analysis of the LBP-ELISA and vaccine protection rate revealed that neutralizing Ab titers greater than 256 provided 100% protection, while titers of 64 and 128 offered 57.1% and 70% protection, respectively. The nbLPB-ELISA is a rapid, simple, safe, and cost-effective method of detecting SVA as a replacement for the SVA VNT and vaccine-challenge assays. KEY POINTS: center dot We evaluated a specific, high-affinity, and neutralizing nanobody-targeting SVA. center dot The developed nbLPB-ELISA can replace viral neutralization tests. center dot The nbLPB-ELISA is suitable to evaluate protective immunity.

分类号：

  • 相关文献

[1]Selection and identification of singledomain antibody against Peste des Petits Ruminants virus. Dan Liu,Lingxia Li,Xiaoan Cao,Jinyan Wu,Guoyu Du,Youjun Shang. 2021

[2]Novel capsid-specific single-domain antibodies with broad foot-and-mouth disease strain recognition reveal differences in antigenicity of virions, empty capsids, and virus-like particles. Haozhou Li,Aldo Dekker,Shiqi Sun,Alison Burman,Jeroen Kortekaas,Michiel M. Harmsen. 2021

[3]Porcine epidemic diarrhea virus virus-like particles produced in insect cells induce specific immune responses in mice. Wang, Cuiling,Wang, Cuiling,Yan, Feihu,Zheng, Xuexing,Wang, Hualei,Jin, Hongli,Wang, Chong,Zhao, Yongkun,Feng, Na,Wang, Tiecheng,Gao, Yuwei,Yang, Songtao,Xia, Xianzhu,Zheng, Xuexing,Jin, Hongli,Wang, Chong,Zheng, Xuexing,Wang, Hualei,Zhao, Yongkun,Feng, Na,Wang, Tiecheng,Gao, Yuwei,Yang, Songtao,Xia, Xianzhu.

[4]Highly pathogenic porcine reproductive and respiratory syndrome virus GP5 B antigenic region is not a neutralizing antigenic region. Leng, Chao-Liang,An, Tong-Qing,Chen, Jia-Zeng,Gong, Da-Qing,Peng, Jin-Mei,Yang, Yong-Qian,Wu, Jiang,Guo, Juan-Juan,Li, Deng-Yun,Zhang, Yi,Meng, Zhen-Xiang,Wu, Yu-Quan,Tian, Zhi-Jun,Tong, Guang-Zhi,Tong, Guang-Zhi.

[5]Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity. Li, Xiaojun,Zhao, Ran,Li, Chenxi,Zhang, Tingting,Meng, Fanyi,Liu, Ming,Zhang, Yun,Lin, Wei.

[6]A spike-specific whole-porcine antibody isolated from a porcine B cell that neutralizes both genogroup 1 and 2 PEDV strains. Fu, Fang,Li, Lin,Shan, Lingling,Yang, Beibei,Shi, Hongyan,Zhang, Jiaoer,Feng, Li,Liu, Pinghuang,Wang, Hongfeng.

[7]Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry. Wang, Jinliang,Yang, Jie,Ge, Jinying,Hua, Ronghong,Liu, Renqiang,Wang, Xijun,Shao, Yu,Sun, Encheng,Wu, Donglai,Wen, Zhiyuan,Bu, Zhigao,Li, Xiaofeng,Qin, Chengfeng. 2016

[8]A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein. Rong Hong Hua,Shu Jian Zhang,Bei Niu,Jin Ying Ge,Ting Lan,Zhi Gao Bu. 2023

[9]Mapping of foot-and-mouth disease virus antigenic sites recognized by single-domain antibodies reveals different 146S particle specific sites and particle flexibility. Harmsen M.M.,Li H.,Sun S.,van der Poel W.H.M.,Dekker A.. 2023

[10]Two cross-protective antigen sites on foot-and-mouth disease virus serotype o structurally revealed by broadly neutralizing antibodies from cattle. Kun Li,Yong He,Li Wang,Pinghua Li,Sheng Wang,Pu Sun,Huifang Bao,Yimei Cao,Xuerong Liu,Guoqiang Zhu,Yali Song,Xingwen Bai,Xueqing Ma,Yuanfang Fu,Hong Yuan,Jing Zhang,Jian Wang,Yingli Chen,Dong Li,Zhiyong Lou,Zaixin Liu,Zengjun Lu. 2021

[11]Development and Validation of a Competitive ELISA Based on Bovine Monoclonal Antibodies for the Detection of Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype A. Yimei Cao,Kun Li,Xiangchuan Xing,Guoqiang Zhu,Yuanfang Fu,Huifang Bao,Xingwen Bai,Pu Sun,Pinghua Li,Jing Zhang,Xueqing Ma,Jian Wang,Zhixun Zhao,Dong Li,Zaixin Liu,Zengjun Lu. 2022

[12]A method for screening CDV microneutralization activity in microvolume samples. Deng X.,Su J.,Hu B.,Bai X.. 2024

[13]A ferritin-based nanoparticle displaying a neutralizing epitope for foot-and-mouth disease virus (FMDV) confers partial protection in guinea pigs. Bingzhou Lu,Yi Ru,Rongzeng Hao,Yang Yang,Huanan Liu,Yajun Li,Yue Zhang,Yuhan Mao,Rui Yang,Yangyang Pan,Sijiu Yu,Haixue Zheng,Yan Cui. 2024

[14]Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs. Hong Huo,Jinming Wang,Chan Li,Shuang Xiao,Han Wang,Jinying Ge,Gongxun Zhong,Zhiyuan Wen,Chong Wang,Qiaoling Lang,Lili Chen,Zilong Wang,Jinliang Wang,Xijun Wang,Xijun He,Yuntao Guan,Lei Shuai,Zhigao Bu. 2024

[15]Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus. Zhao, Bingbing,Sun, Zhenzhao,Wang, Shida,Shi, Zhibin,Jiang, Yongping,Wang, Xiurong,Deng, Guohua,Jiao, Peirong,Chen, Hualan,Wang, Jingfei. 2024

[16]Isolation and characterization of GI-19/L1148-like infectious bronchitis virus in China. Huixin Li,Jiabei Han,Bing Wang,Zongxi Han,Shengwang Liu. 2025

[17]Establishment of a pseudovirus neutralization assay for TGEV. Haojie Wang,Jianxing Chen,Lihong Xue,Yue Sun,Tongqing An,Yue Wang,Hongyan Chen,Changqing Yu,Changyou Xia,He Zhang. 2025

[18]Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O. Cao, Yimei,Li, Fengjuan,Xing, Xiangchuan,Zhang, Huiyan,Zhao, Qiongqiong,Sun, Pu,Fu, Yuanfang,Li, Pinghua,Ma, Xueqing,Zhang, Jing,Zhao, Zhixun,Yuan, Hong,Wang, Jian,Wang, Tao,Bao, Huifang,Bai, Xingwen,Li, Dong,Zhang, Qiang,Li, Kun,Lu, Zengjun. 2025

[19]Remapping the spatial distribution of neutralizing sites and their immunodominance on the capsid of different topotypes of FMDV serotype O by site-directed competitive ELISA for detection of neutralizing antibodies. Zhao, Qiongqiong,Li, Fengjuan,Huang, Shulun,Xing, Xiangchuan,Sun, Ying,Li, Pinghua,Bao, Huifang,Fu, Yuanfang,Sun, Pu,Bai, Xingwen,Yuan, Hong,Ma, Xueqing,Zhao, Zhixun,Zhang, Jing,Wang, Jian,Wang, Tao,Li, Dong,Zhang, Qiang,Qian, Ping,Cao, Yimei,Li, Kun,Li, Xiangmin,Lu, Zengjun. 2025

[20]Emergence and whole-genome sequence of Senecavirus A in Colombia. Sun, D.,Sun, D.,Vannucci, F.,Knutson, T. P.,Marthaler, D. G.,Corzo, C..

作者其他论文 更多>>